Low Molecular Weight Sulfated Chitosan: Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson’s Disease

Venkatesan Manigandan, Jagatheesan Nataraj, Ramachandran Karthik, Thamilarasan Manivasagam, Ramachandran Saravanan, Arokyasamy Justin Thenmozhi, Mohamed Musthafa Essa, Gilles J. Guillemin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present investigation was an attempt to study the effect of low molecular weight sulfated chitosan (LMWSC) on in vitro rotenone model of Parkinson’s disease (PD) by evaluating cell viability, oxidative stress, mitochondrial membrane potential, DNA fragmentation, and apoptosis. Incubation of SH-SY5Y cells with 100 nm rotenone resulted in neuronal cell death, redox imbalanced mitochondrial dysfunction, DNA fragmentation, condensation, and apoptotic cellular morphology. Rotenone exposure enhanced the expression of preapoptotic (cytochrome C (cyto c), caspase-3, -8, -9, and Bax) and down-regulated the expression of anti-apoptotic (Bcl-2) markers. Reduction of the intracellular reactive oxygen species (ROS) levels ensued due to pretreatment of LMWSC along with consequent normalization of antioxidant enzymes, mitigation of rotenone induced mitochondrial dysfunction and apoptosis. Our current findings suggested that LMWSC exhibit the pronounced neuroprotective effects, which could be due to its antioxidant, mitochondrial protection, and anti-apoptotic properties. We thus conclude that LMWSC could be developed as a novel therapeutic molecule for the benefit of reducing the consequences of PD. However, further extensive preclinical and clinical studies are warranted.

Original languageEnglish
JournalNeurotoxicity Research
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Rotenone
Chitosan
Neuroprotective Agents
Parkinson Disease
Molecular Weight
Molecular weight
DNA Fragmentation
Antioxidants
Apoptosis
Oxidative stress
Caspase 8
Mitochondrial Membrane Potential
Cell death
Cytochromes
Mitochondrial DNA
Caspase 3
Oxidation-Reduction
Condensation
Reactive Oxygen Species
Cell Survival

Keywords

  • Apoptosis
  • Mitochondrial dysfunction
  • Neuronal damage
  • Oxidative stress
  • Rotenone
  • Sulfated chitosan

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Manigandan, V., Nataraj, J., Karthik, R., Manivasagam, T., Saravanan, R., Thenmozhi, A. J., ... Guillemin, G. J. (Accepted/In press). Low Molecular Weight Sulfated Chitosan: Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson’s Disease. Neurotoxicity Research. https://doi.org/10.1007/s12640-018-9978-z

Low Molecular Weight Sulfated Chitosan : Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson’s Disease. / Manigandan, Venkatesan; Nataraj, Jagatheesan; Karthik, Ramachandran; Manivasagam, Thamilarasan; Saravanan, Ramachandran; Thenmozhi, Arokyasamy Justin; Essa, Mohamed Musthafa; Guillemin, Gilles J.

In: Neurotoxicity Research, 01.01.2018.

Research output: Contribution to journalArticle

Manigandan, Venkatesan ; Nataraj, Jagatheesan ; Karthik, Ramachandran ; Manivasagam, Thamilarasan ; Saravanan, Ramachandran ; Thenmozhi, Arokyasamy Justin ; Essa, Mohamed Musthafa ; Guillemin, Gilles J. / Low Molecular Weight Sulfated Chitosan : Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson’s Disease. In: Neurotoxicity Research. 2018.
@article{1a4700d033944c2e8b7d64da0b0e8469,
title = "Low Molecular Weight Sulfated Chitosan: Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson’s Disease",
abstract = "The present investigation was an attempt to study the effect of low molecular weight sulfated chitosan (LMWSC) on in vitro rotenone model of Parkinson’s disease (PD) by evaluating cell viability, oxidative stress, mitochondrial membrane potential, DNA fragmentation, and apoptosis. Incubation of SH-SY5Y cells with 100 nm rotenone resulted in neuronal cell death, redox imbalanced mitochondrial dysfunction, DNA fragmentation, condensation, and apoptotic cellular morphology. Rotenone exposure enhanced the expression of preapoptotic (cytochrome C (cyto c), caspase-3, -8, -9, and Bax) and down-regulated the expression of anti-apoptotic (Bcl-2) markers. Reduction of the intracellular reactive oxygen species (ROS) levels ensued due to pretreatment of LMWSC along with consequent normalization of antioxidant enzymes, mitigation of rotenone induced mitochondrial dysfunction and apoptosis. Our current findings suggested that LMWSC exhibit the pronounced neuroprotective effects, which could be due to its antioxidant, mitochondrial protection, and anti-apoptotic properties. We thus conclude that LMWSC could be developed as a novel therapeutic molecule for the benefit of reducing the consequences of PD. However, further extensive preclinical and clinical studies are warranted.",
keywords = "Apoptosis, Mitochondrial dysfunction, Neuronal damage, Oxidative stress, Rotenone, Sulfated chitosan",
author = "Venkatesan Manigandan and Jagatheesan Nataraj and Ramachandran Karthik and Thamilarasan Manivasagam and Ramachandran Saravanan and Thenmozhi, {Arokyasamy Justin} and Essa, {Mohamed Musthafa} and Guillemin, {Gilles J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s12640-018-9978-z",
language = "English",
journal = "Neurotoxicity Research",
issn = "1029-8428",
publisher = "Springer New York",

}

TY - JOUR

T1 - Low Molecular Weight Sulfated Chitosan

T2 - Neuroprotective Effect on Rotenone-Induced In Vitro Parkinson’s Disease

AU - Manigandan, Venkatesan

AU - Nataraj, Jagatheesan

AU - Karthik, Ramachandran

AU - Manivasagam, Thamilarasan

AU - Saravanan, Ramachandran

AU - Thenmozhi, Arokyasamy Justin

AU - Essa, Mohamed Musthafa

AU - Guillemin, Gilles J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The present investigation was an attempt to study the effect of low molecular weight sulfated chitosan (LMWSC) on in vitro rotenone model of Parkinson’s disease (PD) by evaluating cell viability, oxidative stress, mitochondrial membrane potential, DNA fragmentation, and apoptosis. Incubation of SH-SY5Y cells with 100 nm rotenone resulted in neuronal cell death, redox imbalanced mitochondrial dysfunction, DNA fragmentation, condensation, and apoptotic cellular morphology. Rotenone exposure enhanced the expression of preapoptotic (cytochrome C (cyto c), caspase-3, -8, -9, and Bax) and down-regulated the expression of anti-apoptotic (Bcl-2) markers. Reduction of the intracellular reactive oxygen species (ROS) levels ensued due to pretreatment of LMWSC along with consequent normalization of antioxidant enzymes, mitigation of rotenone induced mitochondrial dysfunction and apoptosis. Our current findings suggested that LMWSC exhibit the pronounced neuroprotective effects, which could be due to its antioxidant, mitochondrial protection, and anti-apoptotic properties. We thus conclude that LMWSC could be developed as a novel therapeutic molecule for the benefit of reducing the consequences of PD. However, further extensive preclinical and clinical studies are warranted.

AB - The present investigation was an attempt to study the effect of low molecular weight sulfated chitosan (LMWSC) on in vitro rotenone model of Parkinson’s disease (PD) by evaluating cell viability, oxidative stress, mitochondrial membrane potential, DNA fragmentation, and apoptosis. Incubation of SH-SY5Y cells with 100 nm rotenone resulted in neuronal cell death, redox imbalanced mitochondrial dysfunction, DNA fragmentation, condensation, and apoptotic cellular morphology. Rotenone exposure enhanced the expression of preapoptotic (cytochrome C (cyto c), caspase-3, -8, -9, and Bax) and down-regulated the expression of anti-apoptotic (Bcl-2) markers. Reduction of the intracellular reactive oxygen species (ROS) levels ensued due to pretreatment of LMWSC along with consequent normalization of antioxidant enzymes, mitigation of rotenone induced mitochondrial dysfunction and apoptosis. Our current findings suggested that LMWSC exhibit the pronounced neuroprotective effects, which could be due to its antioxidant, mitochondrial protection, and anti-apoptotic properties. We thus conclude that LMWSC could be developed as a novel therapeutic molecule for the benefit of reducing the consequences of PD. However, further extensive preclinical and clinical studies are warranted.

KW - Apoptosis

KW - Mitochondrial dysfunction

KW - Neuronal damage

KW - Oxidative stress

KW - Rotenone

KW - Sulfated chitosan

UR - http://www.scopus.com/inward/record.url?scp=85056473058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056473058&partnerID=8YFLogxK

U2 - 10.1007/s12640-018-9978-z

DO - 10.1007/s12640-018-9978-z

M3 - Article

AN - SCOPUS:85056473058

JO - Neurotoxicity Research

JF - Neurotoxicity Research

SN - 1029-8428

ER -